Zai Lab to Announce Third Quarter 2022 Financial Results on November 9, 2022
Zai Lab Limited (NASDAQ: ZLAB) announced it will report financial results for Q3 2022 on November 9, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Zai Lab Limited (NASDAQ: ZLAB) announced it will report financial results for Q3 2022 on November 9, 2022, after market close. A conference call and webcast will be held on November 10, 2022, at 8:00 a.m. ET, where the company will provide corporate updates. Investors can register in advance through the provided link. Zai Lab is committed to delivering innovative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders.
Positive
- Upcoming Q3 2022 financial results reporting may provide insight into company performance.
Negative
- None.
Details
News Market Reaction – ZLAB
The recorded move for ZLAB in the trading session of this news was +0.41%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
-- Company to Host Conference Call and Webcast on November 10, 2022, at 8:00 a.m. ET
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that it will report financial results and corporate updates for the three months ended September 30, 2022, after the closing of the U.S. equity markets on November 9, 2022. The Company will host a live conference call and webcast on November 10, 2022, at 8:00 a.m. ET.
Conference Call and Webcast Information
Listeners may access the live webcast by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call. Details are as follows:
Registration Link: https://register.vevent.com/register/BI98db73679f254c8eb1024c9df5ea85a8
All participants must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each participant will receive a dial-in number, Direct Event passcode, and a unique access PIN, which can be used to join the conference call.
A replay will be available shortly after the call and can be accessed by visiting the Company's website at http://ir.zailaboratory.com.
About Zai Lab
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Our goal is to leverage our competencies and resources to positively impact human health worldwide.
For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com and follow us at www.twitter.com/ZaiLab_Global.
For more information, please contact:
Investor Relations: Lina Zhang
+86 136 8257 6943
lina.zhang@zailaboratory.com
Media: Christine Drury / Xiaoyu Chen
+1 (317) 385-9227 / +86 185 0015 5011
christine.drury@zailaboratory.com / xiaoyu.chen@zailaboratory.com
Source: Zai Lab Limited
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.